Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential J Jones, C Causey, B Knuckley, JL Slack-Noyes, PR Thompson Current opinion in drug discovery & development 12 (5), 616, 2009 | 269 | 2009 |
Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor AA Chumanevich, CP Causey, BA Knuckley, JE Jones, D Poudyal, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 300 (6 …, 2011 | 217 | 2011 |
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3 B Knuckley, CP Causey, JE Jones, M Bhatia, CJ Dreyton, TC Osborne, ... Biochemistry 49 (23), 4852-4863, 2010 | 189 | 2010 |
Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors JE Jones, JL Slack, P Fang, X Zhang, V Subramanian, CP Causey, ... ACS chemical biology 7 (1), 160-165, 2012 | 113 | 2012 |
A fluopol-ABPP HTS assay to identify PAD inhibitors B Knuckley, JE Jones, DA Bachovchin, J Slack, CP Causey, SJ Brown, ... Chemical communications 46 (38), 7175-7177, 2010 | 102 | 2010 |
The development of N-α-(2-carboxyl) benzoyl-N 5-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl) benzoyl-N 5-(2-chloro-1-iminoethyl)-l-ornithine … CP Causey, JE Jones, JL Slack, D Kamei, LE Jones Jr, V Subramanian, ... Journal of medicinal chemistry 54 (19), 6919-6935, 2011 | 92 | 2011 |
Design, synthesis, and kinetic characterization of protein N-terminal acetyltransferase inhibitors H Foyn, JE Jones, D Lewallen, R Narawane, JE Varhaug, PR Thompson, ... ACS chemical biology 8 (6), 1121-1127, 2013 | 56 | 2013 |
A chloroacetamidine-based inactivator of protein arginine methyltransferase 1: design, synthesis, and in vitro and in vivo evaluation O Obianyo, CP Causey, T Osborne, JE Jones, YH Lee, MR Stallcup, ... Chembiochem: a European journal of chemical biology 11 (9), 1219, 2010 | 51 | 2010 |
Activity-based protein profiling of protein arginine methyltransferase 1 O Obianyo, CP Causey, JE Jones, PR Thompson ACS chemical biology 6 (10), 1127-1135, 2011 | 49 | 2011 |
Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism CJ Dreyton, B Knuckley, JE Jones, DM Lewallen, PR Thompson Biochemistry 53 (27), 4426-4433, 2014 | 43 | 2014 |
Characterization and inactivation of an agmatine deiminase from Helicobacter pylori JE Jones, CP Causey, L Lovelace, B Knuckley, H Flick, L Lebioda, ... Bioorganic chemistry 38 (2), 62-73, 2010 | 28 | 2010 |
Mechanistic studies of agmatine deiminase from multiple bacterial species JE Jones, CJ Dreyton, H Flick, CP Causey, PR Thompson Biochemistry 49 (43), 9413-9423, 2010 | 21 | 2010 |
Optimization and characterization of a pan protein arginine deiminase (PAD) inhibitor CJ Dreyton, JE Jones, BA Knuckley, V Subramanian, ED Anderson, ... Probe Reports from the NIH Molecular Libraries Program [Internet], 2013 | 16 | 2013 |
COVID-19 etiology and risk factors JE Jones | 1 | 2021 |
Suppression of colitis in mice by Cl-amidine: a novel D Poudyal, AP Chumanevich, T Davis, LE Matesic, PRAA Chumanevich, ... J. Biol. Chem 287 (8), 6062-6071, 2012 | | 2012 |
Kinetic, mechanistic, and inhibition studies on the deiminase family of enzymes JE Jones University of South Carolina, 2010 | | 2010 |
How lab diagnostics can support COVID-19 patient management Dec. 22, 2020 JE Jones | | |